Literature DB >> 16877704

Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells.

Wenwen Chien1, Dong Yin, Dorina Gui, Akio Mori, Jonathan Mordechai Frank, Jonathan Said, Donato Kusuanco, Alberto Marchevsky, Robert McKenna, H Phillip Koeffler.   

Abstract

Connective tissue growth factor (CTGF) is a secreted protein that belongs to CCN family. The proteins in this family are implicated in various biological processes, such as angiogenesis, adhesion, migration, and apoptosis. In this study, we explored the roles of CTGF in lung tumorigenesis. The expression levels of CTGF in 58 lung cancer samples were reduced by >2 fold in 57% of the samples compared with matched normal samples using real-time reverse transcription-PCR. These results were confirmed by immunohistochemical staining for CTGF in normal lung epithelia and lung cancer. Cellular proliferation was inhibited in non-small cell lung cancer (NSCLC) cell lines NCI-H460, NCI-H520, NCI-H1299, and SK-MES-1 by CTGF overexpression. Partially purified CTGF suppressed lung cancer cell growth. The growth inhibition caused by CTGF overexpression was associated with growth arrest at G(0)-G(1) and prominent induction of p53 and ADP ribosylation factor. Most interestingly, overexpression of CTGF suppressed insulin-like growth factor-I-dependent Akt phosphorylation and epidermal growth factor-dependent extracellular signal-regulated kinase 1/2 phosphorylation. In summary, NSCLC cells expressed decreased levels of CTGF compared with normal lung cells; this lower expression has an effect on lung cancer cell proliferation and its cellular response to growth factors. Our data suggest that CTGF may behave as a secreted tumor suppressor protein in the normal lung, and its expression is suppressed in many NSCLCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877704     DOI: 10.1158/1541-7786.MCR-06-0029

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  30 in total

1.  CCN5 Expression in mammals. II. Adult rodent tissues.

Authors:  Mark R Gray; Jennifer A Malmquist; Matthew Sullivan; Michael Blea; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-13       Impact factor: 5.782

2.  Evaluation of tumor metastasis-associated markers for molecular classification in patients with esophageal squamous cell carcinoma.

Authors:  Jun-Xing Huang; Juan Yao; Mao-Song Lin; Mei Lin; Wei Xiao; Hong Yu; Ping Chen; Rong-Yu Qian
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis.

Authors:  Wenwen Chien; James O'Kelly; Daning Lu; Amanda Leiter; Julia Sohn; Dong Yin; Beth Karlan; Jay Vadgama; Karen M Lyons; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2011-03-23       Impact factor: 5.650

4.  Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.

Authors:  A Koch; A Völzke; C Wünsche; D Meyer zu Heringdorf; A Huwiler; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

5.  Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.

Authors:  Carl E Allen; Jianguo Du; Bo Jiang; Qin Huang; Adam J Yakovich; John A Barnard
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.

Authors:  Verena Thewes; Francesca Orso; Richard Jäger; Dawid Eckert; Sabine Schäfer; Gregor Kirfel; Stephan Garbe; Daniela Taverna; Hubert Schorle
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

7.  Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro.

Authors:  Patricia Garcia; Pamela Leal; Carmen Ili; Priscilla Brebi; Hector Alvarez; Juan C Roa
Journal:  Int J Exp Pathol       Date:  2013-04-18       Impact factor: 1.925

8.  CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.

Authors:  Elsa Sánchez-López; Sandra Rayego; Raquel Rodrigues-Díez; Javier Sánchez Rodriguez; Raúl Rodrigues-Díez; Juan Rodríguez-Vita; Gisselle Carvajal; Luiz Stark Aroeira; Rafael Selgas; Sergio A Mezzano; Alberto Ortiz; Jesús Egido; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

9.  Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.

Authors:  Mei-Hong Li; Teresa Sanchez; Anna Pappalardo; Kevin R Lynch; Timothy Hla; Fernando Ferrer
Journal:  Mol Cancer Res       Date:  2008-10       Impact factor: 5.852

10.  Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer.

Authors:  Ryoko Kikuchi; Yoshihiro Kikuchi; Hitoshi Tsuda; Hitoshi Maekawa; Ken-Ichi Kozaki; Issei Imoto; Seiichi Tamai; Akihiro Shiotani; Keiichi Iwaya; Masaru Sakamoto; Takao Sekiya; Osamu Matsubara
Journal:  Hum Cell       Date:  2014-04-04       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.